What's breaking now, across thousands of outlets.
Norah O'Donnell tells Laurie Cox why she started studying the gut microbiome and what she eats to keep hers happy.
We haven't written up this one. CBS News has the full story — the link below goes straight to it.
Dr. Danish Nagda, a shareholder in the developer, told Fortune it was "incredibly exciting ... maybe half a decade away from the post-cancer era."
In a late-stage study, RevMed’s Rasonque helped subjects live to 13 months, nearly twice as long as those who only received chemotherapy.
Click in for more news from The Hill {beacon} Healthcare Healthcare The Big Story Kennedy feuds with Shapiro over vaccines An online row between Health and Human Services Secretary Robert F.
Meta agreed to pay up to $17 billion in a settlement, putting to rest a trial where dozens of states accused it of deliberately endangering children through their platforms.
Laura Syron: Addressing food security will lower Canadians’ risk of developing type 2 and gestational diabetes, improve outcomes for those living with diabetes, and ultimately decrease health-care…
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.
